- Timezone: Europe/Paris
- Date: Nov 29 2022 - Dec 02 2022
- Time: 8 h 00 min
- Nov 29 2022 - Dec 02 2022
- 8 h 00 min
15TH Clinical Trials on Alzheimer’s Disease (CTAD22)
The Clinical Trials on Alzheimer’s Disease conference (CTAD) is a meeting focused entirely on Alzheimer’s Disease Therapeutic Trials with key leaders in Alzheimer Disease research from Industry and Academia getting together and forming partnerships with the objective of speeding the development of effective treatments to fight the disease.
The 15th annual CTAD conference will be held in San Francisco on November 29 – December 2, 2022.
Looking forward to seeing you in San Francisco!
CTAD22 Call for abstracts
Call for abstracts is closed.
Late call for abstracts is open!
Deadline: September 30, 2022
CTAD is the only meeting focused entirely on Alzheimer’s Disease Therapeutic Trials.
Do not miss this chance to showcase your work in AD therapeutic trials.
More information on abstracts submission by clicking here
Preliminary program is online!
CTAD22 registrations are open!
Early bird fees until october 15
Hilton Union Square.
“333 O’Farrell Street – San Francisco, CA 94102, USA”
More information on the ctad website by clicking here